In cancer cell lines without these mutations, PLX4032 had minimal or no effects on ERK phosphorylation and DR5 expression while AZD6244 continued to decrease ERK phosphorylation and DR5 expression (Fig. 1A). The gene discussed is TNFRSF10B; the disease is cancer.